Cortes, J. ., Gambacorti-Passerini, C. ., Deininger, M. ., Mauro, M. ., Chuah, C. ., Kim, D. ., … Brümmendorf, T. . (2018). Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 36(3), 231-237. https://doi.org/10.1200/JCO.2017.74.7162 (Original work published 2018)